IN THE NEWS
G&W Laboratories, a small generic drugmaker, recently broke onto the pharma scene publicly with two substantial deals in 10 months for plants and products.
March 12, 2015 -- South Plainfield, NJ – The Board of Directors of G&W Laboratories has appointed Dr. Aaron Greenblatt as its new Chief Executive Officer.
Teva Pharmaceutical Industries Ltd. has agreed to sell its Pennsylvania facilities to G&W Laboratories Inc. as part of the Israeli company's cost-reduction program.
For the second time in about 9 months, a privately held New Jersey company has saved a manufacturing plant from closing and hundreds of jobs from being lost.